Sign up to receive the weekly WA Innovation Calendar Newsletter!  Sign up here
X

World Mosquito Program

How can mosquitos be used to combat disease?

Innovation comes in many forms. This month we will hear from Ben Green, Executive Director Technology Innovation at World Mosquito Program (WMP), as he talks about how the WMP is protecting communities around the world from mosquito-borne diseases using mosquitos!

In this engaging session Ben will provide:

  • an overview of the World Mosquito Program (WMP)
  • a snapshot of the global dengue burden
  • information about the innovative Wolbachia method employed by the WMP
  • information about how the WMP partners with governments and communities
  • the evidence portfolio for impact
  • an outline of how to innovate for scale, including mosquito production, distribution and release.

There will be nibbles and drinks provided and opportunities to network!

Seats are limited so book your place at this engaging session today: events.humanitix.com/the-world-mosquito-program

DEADLINE: Nature Awards Healthspan Accelerator

Are you a researcher with aspirations to translate your life science discovery into real world practice to improve the human healthspan?

Do you need guidance to advance from early discovery to commercial launch, with support from leading translation experts and venture builders? 

Four carefully chosen applicants will each be awarded a $10,000 Nature Award and gain entry to the residential accelerator programme. Here, you’ll engage with eminent scientistentrepreneurs and explore opportunities for commercial development, all aimed at advancing your cutting-edge science into viable health innovations. We are especially interested in passionate scientists early in their career leading the work alongside a seasoned PI.

 In 2025, the accelerator will focus on four key areas:

  • regulating host metabolism and the rate of aging
  • better identifying and mediating aging cells
  • reducing risk factors and slowing neurodegeneration
  • attenuating age-associated inflammation

Learn more about the Nature Awards Healthspan Accelerator: https://www.nature.com/immersive/healthspanaccelerator/index.html

ANDHealth: Supercharge Your US Expansion

Supercharge Your US Expansion: Exclusive Webinar Series from ANDHealth

Are you exploring US healthcare market opportunities or preparing for your first steps into the world’s largest health system? Don’t miss this exclusive four-part virtual series from ANDHealth, designed for digital and connected health innovators ready to accelerate international growth.

What you’ll gain:

  • Real-world advice and actionable frameworks from US investors, market access experts and Australian founders who’ve done it before
  • Exclusive insights from the ANDHealth team, who have been supporting Australian companies to expand to the US through international delegations since 2020
  • Practical, tailored strategies to sharpen your US approach for 2025 and beyond

DEADLINE: ANDHealth+Program

ANDHealth+ is a commercialisation acceleration program for innovative digital and connected health technologies with demonstrable commercial and clinical impact potential. It is a national program that is designed to be delivered virtually, Australia-wide. All Australian SMEs which meet the eligibility criteria are encouraged to apply.
The two-stage program supports proof-of-concept stage, evidence-based digital and connected health SMEs through:
  • Up to $5 million non-dilutive project funding, tranched according to agreed milestones
  • Significant in-kind support, specialised expertise and hands-on resources
  • A global network of industry advisors, investors, clinicians, executives and corporate partners
  • Cohort and alumni-only events and opportunities
  • With no equity requirements or IP transfer.
Selected participants will work with a dedicated ANDHealth support team and an Industry Advisory Panel to address and overcome key challenges along the commercialisation pathway.

Each intake, up to five companies are selected via a proven and competitive assessment process, driven by a multi-sectoral, multi-disciplinary group of industry leaders with experience in evaluating and selecting high-potential SMEs.

Information Session: Raising Capital in 2026

MTPConnect, Australia’s Life Sciences Innovation Accelerator and Wholesale Investor, a leading private capital marketplace announced a landmark strategic partnership to provide a comprehensive capital engagement program for life science companies.

The program will formally launch this month with an Information Session: Raising Capital in 2026 on 15 October 2025 at 5:00pm AEDT

Register here: Information Session: Raising Capital in 2026

DEADLINE: MTAA Committee Nominations

The Medical Technology Association of Australia is now calling for applications to join MTAA’s Strategic Committees. These Committees provide a vital link between industry members, the Board and MTAA. The purpose of each Committee is to support the Board in the strategic development and delivery of Association policies in matters pertinent to its expertise.

Applications are invited annually by MTAA from employees of MTAA voting Members. The term of office for a committee member will be two years, with members eligible for reappointment for a further two years. The Committee will meet not less than 4 times per year.

Learn more here: https://www.mtaa.org.au/committee-nominations

Innovation in Medicine 2025

A flagship student-industry event, with an insightful panel discussion centred around the theme: the Evolution of Biomedical Engineering.

Panelists will share valuable insights into the advancements and transformations within biomedical engineering, highlight the variety of roles across the medtech industry, and reflect on their unique career journeys.

Perth Protein Group AGM 2025 at Harry Perkins Institute of Medical Research

This is your chance to network with fellow protein enthusiasts, hear from representatives of Perth based core research facilities, hear about the latest research in protein biochemistry, molecular biology, biomedical research and synthetic biology, and contribute to the future of protein science.

DEADLINE: Innovation Consultant (South Metropolitan Health Service)

South Metropolitan Health Service (SMHS) is seeking a forward-thinking Innovation Consultant to collaborate with the Transformation and Organisational Development team, driving the discovery of new growth opportunities and sustaining a competitive advantage within the rapidly evolving healthcare sector.

The successful applicant/s shall be responsible for enabling and supporting innovation within the South Metropolitan Health Service by fostering a culture of open collaboration, engaging and networking with a variety of internal and external stakeholders and managing the operations of the SMHS innovation function and space, the Kaartdijin